Emerald Mutual Fund Advisers Trust’s Sage Therapeutics SAGE Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-126,626	Closed	-$20.4M	–	256
2018 Q1	$20.4M	Sell	126,626 -6,697	-5%	-$1.14M	0.8%	38
2017 Q4	$22M	Buy	133,323 +70,615	+113%	+$6.85M	0.87%	28
2017 Q3	$3.91M	Sell	62,708 -87,565	-58%	-$6.88M	0.16%	166
2017 Q2	$12M	Buy	150,273 +49,822	+50%	+$3.6M	0.52%	69
2017 Q1	$7.14M	Buy	+100,451	New	+$5.88M	0.33%	110

Other funds holding SAGE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's SAGE Position: Q2 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of Sage Therapeutics (SAGE) in Q2 2018, closing a stake of 126,626 shares — an estimated $20.4M sold.

Emerald Mutual Fund Advisers Trust first reported a position in SAGE in Q1 2017 and held it in 5 quarters. The position peaked at $22M in Q4 2017. 269 funds tracked by Wall St. Rank hold SAGE as of Q2 2018.

Emerald Mutual Fund Advisers Trust reported no remaining Sage Therapeutics position as of Q2 2018 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 126,626 Sage Therapeutics shares in Q2 2018, an estimated $20.4M.
Emerald Mutual Fund Advisers Trust first reported a position in Sage Therapeutics in Q1 2017 and held it in 5 quarters.
Emerald Mutual Fund Advisers Trust's Sage Therapeutics position peaked at $22M in Q4 2017.
269 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2018, filed 31 Jul 2018.